Vincent Hammersen1, Michael Wolff2, Andreas Rennings3, and Gregor Schaefers1,2
1MRI-STaR GmbH, Gelsenkirchen, Germany, 2MR:comp GmbH, Gelsenkirchen, Germany, 3General and Theoretical Electrical Engineering (ATE), University of Duisburg-Essen, Duisburg, Germany
Synopsis
MR
safety of AIMD with leads is assessed test procedures defined in ISO/TS10974.
This separates the different electromagnetic field interactions into
independent test procedures. E.g., malfunction and rectification testing, with
gradient and RF injection networks connected to the lead ports of AIMDs. But
this does not correspond to "realistic MRI exposures", where a
precise combination of RF and magnetic fields is used for imaging. For this
reason, a concept is being proposed in which both injection networks are
combined to allow a concerted exposure. This allows the simultaneous exposition of any
gradient and RF signal combination.
INTRODUCTION
Testing
of active implantable medical devices (AIMDs) for MR safety is performed
according to the procedures defined in ISO/TS 109741. These
procedures are separated in different physical hazards, which are investigated
mostly independently from others. This also applies to the testing of AIMDs with
electrically long leads, for RF-induced malfunctions or rectification products
(Clause15), as well as for gradient-induced malfunctions or extrinsic
potentials (Clause16 and 13). In these clauses the devices main bodies are
exposed to, previously determined, worst-case test levels by connecting their
electrode lead entry points via so called injection networks. Although the approach of these isolated worst-case exposures is already
well implemented in testing routines, this separation does not represent a “realistic”
clinical case, as MR imaging relies on a precise combination of RF and Gradient
exposures. Out of this context, this study presents a concept
for a combined RF & Gradient injection network. By applying this, the worst-cases
of both test methods can be applied simultaneously, as well as the impact of
"realistic" MR pulse sequences on AIMDs can be investigated.METHODS
The injection networks are
described in the ISO/TS 10974 and consist of several components, which are
connected to the DUT via 50Ω lines (cf. Fig1). For the
RF injection network these components are typically: 1. signal sources & amplifiers;
2. circulators or attenuators to prevent reflections; 3. splitters for multiple
single electrode lines in common mode; 4. couplers for power input and output
monitoring and 5. bias tees to separate the ingoing RF and rectified DC power.
Potential rectified power levels are monitored via an oscilloscope at the DC
port of the bias tees. The network for reproducing the gradient induced power
levels in the DUT typically consist of: 1. Signal source; 2. a tissue interface
network for monitoring the AIMD response; 3. a tissue simulating impedance
(standard 250 Ω) and 4. For detecting the extrinsic potential a 1 MΩ differential
probe is connected to the input line and the return line/AIMD casing.
Given that the bias tees are
the last component of the RF network and separate high- and low-frequency
components, it is an uncomplicated
solution to use them as a connector for the combined gradient and RF network. A
combined network creates the possibility to expose the AIMD to any combination
of low and high frequency test signals (shape, duration, magnitude, phase
shift). This also includes "realistic MR sequences". MR sequence
diagrams can be converted into electrical induction timing sequence for
gradient and RF power exposition. To cover the combined malfunction tests,
suitable gradient and RF levels must be applied simultaneously over the defined
exposure time. The differential probe used for detecting the extrinsic
potentials and charges of Clause 13 can also be used to measure the RF-power
rectified products of Clause 15.
To illustrate the
applicability (see Fig2), a full-wave rectifier consisting of 4 diodes was used
as dummy, to rectify gradient (10kHz) as well as RF-frequencies (64
MHz). A 64
MHz square wave pulse and a burst of 6 consecutive 10 kHz square wave pulses
with negative bias were used as the test signal.RESULTS
The concept proven to be solid, and the combinations and magnitude phase shifts of the combined injected test signals is only limited by the power ratings of the network components and the technical specifications of the arbitrary waveform generators.With the voltage bias of the gradient 10 kHz square signal the required minimum voltage of 0.7 V of the Si diodes (cf. Fig 2) was exceeded and a rectification of the RF signal of approx. 100 mV could be observed (red) for the rest of the RF pulse. This rectification could be confirmed by the decreased
power levels observed by the bidirectional coupler for the reflected RF signal
(blue) and, remarkably, also for the forward signal (green). However, as can be seen from the gradient input monitor signal (yellow) and the voltage across the tissue resistor (red), there were voltage spikes of unknown origin at the starting flank of the square pulses.DISCUSSION
The otherwise separately
evaluated response of a DUT to injected gradient and RF signals can be easily
coupled via bias tees. This allows the generation of a “concerted worst-case"
situation. The standard long-term exposure of 30 minutes for combined
malfunction checks is possible, especially since the monitoring ports of the
networks remain in place. With the aid of a dummy, it can be shown that
rectified RF can also be measured at the tissue resistance using a 1 MOhm
test probe. This is different from the standard measurement of RF rectification
products at the DC port of the bias tee at 50 Ω. Also, the impact of the
reflected 64 MHz signal at the tissue resistance is missing. However, for
this purpose it is possible to replace the bias tee with a simple DC block and
a 50 Ω coaxial Tee connector (cf. Fig 3). Although only one combined
injection line was used for demonstration purposes, it is possible to use any
number of lines to contact each electrode of the AIMD individually. By phase
shifting single or multiple lines, differential exposure analysis could also be
performed.Acknowledgements
No acknowledgement found.References
1. Technical specification ISO/TS
10974:2018 “Assessment of the safety of magnetic resonance imaging for patients
with an active implantable medical device”. The International Organization for
Standardization. 2018.